3rd Intrenational Conference on Chronic Obstructive Pulmonary Disease July 11-12, 2016 Brisbane, Australia

Prof. Ping Yang has completed her MD from Beijing Medical College in China and PhD at Johns Hopkins University in USA. She has been leading a comprehesive lung cancer research program at Mayo Clinic since 1997, emphasizing patient-centered outcome research with COPD as one of the key interaested areas. She has published more than 200 peer-reviewed papers and has been serving as an editorial board member of Jounal of Clinical Oncology and Associate Editir of Journal of Thoracic Oncology.

Thoracic oncology, COPD Realted to Cancer

Tsukasa Kadota graduated from Jikei University School of Medicine where he also completed his residency in pulmonary medicine. He is a research associate at The Jikei University School of Medicine and a visiting scientist at National Cancer Center Research Institute.

Pulmonary disease, COPD, Respiratory

Joaquim Gea obtained his MD (1979) and PhD (1989) degrees at the Universitat de Barcelona, being specialist in both Internal Medicine (1981) and Respiratory Medicine (1985). He is the Head of the Respiratory Department at Hospital del Mar, Full Professor and Dean of the School of Medicine at Universitat Pompeu Fabra and Deputy Director at the Spanish Network of Excellence for Research in Respiratory Diseases (CIBERES). He has been funded by 65 competitive grants, including 4 projects funded by the European Commission, and published more than 260 Original Articles and Reviews in peer reviewed journals as well as 50 book chapters.

COPD, Respiratory Diseases

Dr. Patrick Vanscheeuwijck is Director pre-clinical toxicology at Philip Morris International, Reduced Risk Products, and Switzerland, responsible for the in vitro and in vivo assessment of Reduced Risk Products (RRPs). The focus of his career at PMI has been on the development of approaches for the assessment of hazard associated with cigarette smoke and aerosols from RRPs, inhalation toxicology and animal models of disease; with more than 30 peer-reviewed publications. He has a Ph.D. in biochemical pharmacology (University of Gent, Belgium), performed postdocs at the University of Arizona, U.S. and the University of Leuven, Belgium in molecular pharmacology and molecular biology.

COPD, Emphysema, Toxicology

Director in Respiratory care

lot of work around COPD management and controlling prevention of exacerbations

Reearch in Inferctious Diseases

Drug discovery and drug screening to combat infectious diseases.

Lead of the global Allergy and Respiratory Team in Medical Services; and currently he is Senior Medical Director and Chair of the Allergy and Respiratory Center of Excellence.

He is experienced in global product management and life cycle developments. Before joining Quintiles, he was the medical lead for three compounds currently marketed.

More than 190 publications in international journals, transactions and proceedings in the areas of Modelling, Biomechanical Engineering, System Dynamics and Controls, Vibration of Structures, and Mechanical Design. Chairing and organising more than 32 symposiums

Respiratory System Dynamics Cardiovascular System Dynamics

experience as a teacher, researcher and clinician over 35 years.He has been the President and office bearer of a couple of scientific bodies and is associated with a number of scientific journals.

Pulmonary Medicine, COPD